Text Citations
Citation 1: Genelink. Retrieved March 29, 2013, from http://www.genelink.com/
Citation 2: Keefe, A. D., Pai, S., & Ellington, A. (2010). Aptamers as therapeutics. Nature, 537-550. doi: 10.1038/nrd3141. Retrieved March 29, 2013 from http://vetbiotech.um.ac.ir/parameters/vetbiotech/filemanager/new_admin/Selected%20Articles/series_7/51882778.pdf
Citation 3: IUPAC. Compendium of Chemical Terminology, 2nd ed. (the "Gold Book"). Compiled by A. D. McNaught and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997). XML on-line corrected version: http://goldbook.iupac.org (2006-) created by M. Nic, J. Jirat, B. Kosata; updates compiled by A. Jenkins. ISBN 0-9678550-9-8. doi:10.1351/goldbook.
Last update: 2012-08-19. Retrieved March 29, 2013, from http://goldbook.iupac.org/O04282.html
Citation 4: Carlson, B. (2007). Aptamers: The New Frontier In Drug Development? Biotechnology Healthcare. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555175/
Citation 5: Kuk, J., Lee, E., Jang, B., & Lam, J. (n.d.). RNA Aptamers. Index. Retrieved March 29, 2013, from http://bio349.biota.utoronto.ca/20069/bio349jerry1/
Citation 6: Song K-M, Lee S, Ban C. Aptamers and Their Biological Applications. Sensors. 2012; 12(1):612-631. Retrieved March 29, 2013, from http://www.mdpi.com/1424-8220/12/1/612
Citation 7: Stratis-Cullum, D. N. (n.d.). Aptamer Based Detection of Hazardous Materials for Defense and Security. In A. S. Finch (Author). Retrieved March 29, 2013, from https://www.novapublishers.com/catalog/product_info.php?products_id=37683
Citation 8: Aquino-Jarquin G, Toscano-Garibay JD. RNA Aptamer Evolution: Two Decades of SELEction. International Journal of Molecular Sciences. 2011; 12(12):9155-9171. Retrieved March 29, 2013 from http://www.mdpi.com/1422-0067/12/12/9155
Citation 9: Shigdar, S., Luczo, J., Wei, M. Q., Bell, R., Danks, A., Liu, K., & Duan, W. (2010). Aptamer Therapeutics: The 21 st Century's Magic Bullet of Nanomedicine | Sarah Shigdar - Academia.edu. The Open Conference Proceedings Journal, 118-124. Retrieved March 29, 2013, from http://www.academia.edu/1122190/Aptamer_Therapeutics_The_21_st_Centurys_Magic_Bullet_of_Nanomedicine
Citation 10: Aptagen. (2013). Aptamers. Retrieved March 29, 2013, from http://www.aptagen.com/home.aspx
Citation 11: Influenza A Specific DNA Aptamers. (2010, January 25). Office for Technology Commercialization. Retrieved March 29, 2013, from http://www.license.umn.edu/Products/Influenza-A-Specific-DNA-Aptamers__20130017.aspx
Citation 12: Schuitt, S. M. (2013). An Overview of the SELEX Process. TriLink Biotechnologies. Retrieved March 29, 2013, from www.trilinkbiotech.com/tech/selex.asp
Citation 13: TU Darmstadt's biosensor can diagnose African sleeping sickness before it breaks out. (2012, December 13). Retrieved March 29, 2013, from http://www.news-medical.net/news/20121213/TU-Darmstadte28099s-biosensor-can-diagnose-African-sleeping-sickness-before-it-breaks-out.aspx
Citation 14: Baird, G. S. (2010). Where Are All the Aptamers? American Journal of Clinical Pathology, 529-531. doi: 10.1309/AJCPFU4CG2WGJJKS. Retrieved March 29, 2013 from http://ajcp.ascpjournals.org/content/134/4/529.full
Citation 15: MU Program in Virology and Molecular Therapy. (2009, December 28). MU Researcher Refining Synthetic Molecules to Prevent HIV Resistance. Retrieved March 29, 2013, from http://virology.missouri.edu/slideshow/burke/
Citation 16: UNAIDS World AIDS Day Report 2012. Retrieved March 29, 2013 from http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/JC2434_WorldAIDSday_results_en.pdf
Citation 17: HIV/AIDS. (2013, March 20). Centers for Disease Control and Prevention. Retrieved March 29, 2013, from http://www.cdc.gov/hiv/default.htm
Citation 18: RxList.com. Retrieved March 29, 2013, from http://www.rxlist.com
Citation 19: Neff, C. P., Zhou, J., Remling, L., Kuruvilla, J., Zhang, J., Li, H., ... Akkina, R. (2011). An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice. Sci Transl Med. doi: 10.1126/scitranslmed.3001581. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138523/
Citation 20: Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009, March 6). The challenge of finding a cure for HIV infection. National Center for Biotechnology Information. doi: 10.1126/science.1165706. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/19265012
Citation 21: Ditzler, M. A., Bose, D., Shkriabai, N., Marchand, B., Sarafianos, S. G., Kvaratskhelia, M., & Burke, D. H. (2011). Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates. Nucleic Acids Research, 8237-8247. doi: 10.1093/nar/gkr381. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185408/
Citation 22: Pittsburgh Supercomputing Center. Retrieved March 29, 2013, from http://www.psc.edu/science/madrid2000.html
Citation 23: Ditzler, M. A., Lange, M. J., Bose, D., Bottoms, C. A., Virkler, K. F., Sawyer, A. W., ... Burke, D. H. (2012, December 14). High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase. National Center for Biotechnology Information. doi: 10.1093/nar/gks1190. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561961/
Citation 24: PDL Biopharma. Retrieved March 29, 2013, from http://pdl.com/
Citation 25: "Antibody" entry in the Medical Dictionary. Retrieved March 29, 2013, from http://medical-dictionary.thefreedictionary.com/complete+antibody
Citation 27: Understanding Cancer Series: The Immune System. (n.d.). National Cancer Institute. Retrieved March 29, 2013, from http://www.cancer.gov/cancertopics/understandingcancer/immunesystem/AllPages
Citation 28: Jenna Bioscience. Retrieved March 29, 2013, from http://www.jenabioscience.com/
Citation 29: Mandal, A. (n.d.). Antibody - What is an Antibody? The Medical News. Retrieved March 29, 2013, from http://www.news-medical.net/health/Antibody-What-is-an-Antibody.aspx
Citation 30: Tamarkin, D. A. (n.d.). How antibodies work. Lecture. Retrieved March 29, 2013, from http://faculty.stcc.edu/AandP/AP/AP2pages/Units21to23/immune/abwork.htm
Citation 31: "Monoclonal Antibody" entry in the Medical Dictionary. Retrieved March 29, 2013, from http://medical-dictionary.thefreedictionary.com/monoclonal+antibody
Citation 32: Kimball, J. (n.d.). Monoclonal Antibodies. Lecture. Retrieved March 29, 2013, from http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/M/Monoclonals.html
Citation 33: Bakalar, N. (2012, October 30). Monoclonal Antibodies, 1979. The New York Times. Retrieved March 29, 2013, from http://www.nytimes.com/2012/10/30/health/first-mention-monoclonal-antibodies-in-the-new-york-times.html?_r=1&
Citation 34: Monoclonal antibodies. (2012, February 22). Monoclonal Antibodies. Retrieved March 29, 2013, from http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-monoclonal-antibodies
Citation 35: About monoclonal antibodies. (n.d.). : Cancer Research UK : CancerHelp UK. Retrieved March 29, 2013, from http://www.cancerresearchuk.org/cancer-help/about-cancer/treatment/biological/types/about-monoclonal-antibodies
Citation 36: Monoclonal Antibody Production. (1999). In Monoclonal Antibody Production. Retrieved March 29, 2013, from http://www.nap.edu/openbook.php?record_id=9450&page=22
Citation 37: What Is Age-Related Macular Degeneration? (2013). EyeSmart. Retrieved March 29, 2013, from http://www.geteyesmart.org/eyesmart/diseases/amd.cfm
Citation 38: Age-Related Macular Degeneration. (n.d.). American Optometric Association. Retrieved March 29, 2013, from http://www.aoa.org/Macular-Degeneration.xml
Citation 39: Kozarsky, A. (2012, September 9). Age-Related Macular Degeneration Overview. WebMD. Retrieved March 29, 2013, from http://www.webmd.com/eye-health/macular-degeneration/age-related-macular-degeneration-overview
Citation 40: Age-Related Macular Degeneration (ARMD). (n.d.). Beltina.org - Encyclopedia of Health. Retrieved March 29, 2013, from http://www.beltina.org/health-dictionary/age-related-macular-degeneration-armd-symptoms-treatment.html
Citation 41: Macugen. Retrieved March 29, 2013 from http://www.macugen.com/default.asp
Citation 42: Macugen. Retrieved March 29, 2013 from http://www.rxlist.com/macugen-drug.htm
Citation 43: Kosower, N. S., & Kornspan, J. D. (2012). Chapter 3: Contamination of Tissue Cultures by Mycoplasmas. In S. Rottem (Author) & L. Ceccherini-Nelli & B. Matteoli (Eds.), Biomedical Tissue Culture. doi: 10.5772/51518. Retrieved March 29, 2013, from http://www.intechopen.com/books/biomedical-tissue-culture/contamination-of-tissue-cultures-by-mycoplasmas
Citation 44: Paul Ehrlich - Biography. (n.d.). Nobelprize.org. Retrieved March 29, 2013, from http://www.nobelprize.org/nobel_prizes/medicine/laureates/1908/ehrlich-bio.html
Citation 45: The Nobel Prize in Physiology or Medicine 1984. (n.d.). Nobelprize.org. Retrieved March 29, 2013, from http://www.nobelprize.org/nobel_prizes/medicine/laureates/1984/#
Citation 46: Smith, S. L. (1996, September). Ten years of Orthoclone OKT3 (muromonab-CD3): A review. National Center for Biotechnology Information. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pubmed/9188368
Citation 47: Larry Gold and Craig Tuerk (NeXstar Pharmaceuticals, Boulder, USA). (n.d.). EPO. Retrieved March 29, 2013, from http://www.epo.org/learning-events/european-inventor/finalists/2006/Gold.html
Citation 48: Larry Gold. (n.d.). University of Colorado. Retrieved March 29, 2013, from http://biofrontiers.colorado.edu/about/directory/lgold
Citation 49: Somalogic. Retrieved March 29, 2013, from http://www.somalogic.com/
Citation 50: The Aptamer Lounge. Retrived March 29, 2013, from http://www.aptamers.com/
Citation 51: Andrew Ellington. (n.d.). University of Texas Chemistry Department. Retrieved March 29, 2013, from http://www.cm.utexas.edu/andrew_ellington
Citation 52: The Ellington Lab. Retrieved March 29, 2013, from http://ellingtonlab.org/index.html
Citation 53: Lucerna Biotechnologies. Retrieved March 29, 2013, from http://www.lucernatechnologies.com/About-Us-17.html
Citation 54: Noxxon Pharma. Retrieved March 29, 2013, from http://www.noxxon.com/
Citation 55: Merriam Webster. Retrieved March 29, 2013, from http://www.merriam-webster.com/
Citation 56: Dictionary.com. Retrieved March 29, 2013, from http://dictionary.reference.com/
Citation 57: Development & Approval Process (Drugs). (2012, November 15). Food and Drug Administration. Retrieved March 29, 2013, from http://www.fda.gov/drugs/developmentapprovalprocess/default.htm
Citation 58: Stages of Drug Development. (n.d.). Stages of Drug Development. Retrieved March 29, 2013, from http://www.pacificbiolabs.com/drug_stages.asp
Citation 59: Atomic mass unit. (n.d.). Reading. Retrieved March 29, 2013, from http://www.princeton.edu/~achaney/tmve/wiki100k/docs/Atomic_mass_unit.html
Citation 60: Proceedings of the National Academy of Sciences of the United States of America, 8898-8902. (2002). doi: 10.1073/pnas.132067399. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC124395/
Citation 61: Dua, P., Kim, S., & Lee, D. (2011). Nucleic acid aptamers targeting cell-surface proteins. Methods, 54(2), 215-225. doi: 10.1016/j.ymeth.2011.02.002. Retreived March 29, 2013, from http://www.sciencedirect.com/science/article/pii/S1046202311000375
Citation 62: Zhang, Y., Hong, H., & Cai, W. (2012). Tumor-Targeted Drug Delivery with Aptamers. NIHPA Author Manuscripts. Retrieved March 29, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205327/
Citation 63: Gusnowski, E. (2011, February 21). (Cancer) Target Acquired [Web log post]. Retrieved March 29, 2013, from http://www.scienceinseconds.com/blog/Cancer-Target-Acquired
Citation 64: Morehead State University Faculty Profiles: Craig Tuerk. Retrieved March 29, 2013, from http://www.moreheadstate.edu/content_template.aspx?id=2942
Citation 65: Howard Hughes Medical Institute. Retrieved March 29, 2013, from http://www.hhmi.org/
Citation 66: Biological and Biomedical Sciences at Harvard Medical School: Jack W. Szostak. Retrieved March 29, 2013, from http://dms.hms.harvard.edu/BBS/fac/Szostak.php
Citation 67: University of Missouri School of Medicine. Retrieved March 29,2013 from http://medicine.missouri.edu/
Citation 68: The Joyce Laboratory. Retrieved March 29, 2013, from http://www.scripps.edu/research/faculty/joyce
Citation 69: Gilead Sciences. Retrieved March 29, 2013, from http://www.gilead.com/
Citation 70: Polyclonal Antibodies vs. Monoclonal Antibodies. (n.d.). Randox Life Sciences. Retrieved March 29, 2013, from http://www.randox-lifesciences.com/articles/57?articleSectionId=1
Citation 71: Scheinfeld, N. S. (2013, February 27). Intravenous Immunoglobulin . Intravenous Immunoglobulin. Retrieved March 29, 2013, from http://emedicine.medscape.com/article/210367-overview
Citation 72: Aptamer Sciences, Inc. Retrieved March 29, 2013, from http://www.aptsci.com/
Citation 73: AptaMatrix, Inc. Retrieved March 29, 2013, from http://www.aptamatrix.com/
Citation 74: Base Pair Biotechnologies. Retrieved March 29, 2013, from http://www.basepairbio.com/
Citation 75: NeoVentures Biotechnology. Retrieved March 29, 2013, from http://neoventures.ca/
Citation 76: AMBiotech. Retrieved March 29, 2013, from http://www.thioaptamer.com/
